Template:Lymphangioma: Difference between revisions

	Lymphangioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lymphangioma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Lymphangioma On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lymphangioma All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lymphangioma
CDC on Lymphangioma
Lymphangioma in the news
Blogs on Lymphangioma
Directions to Hospitals Treating Lymphangioma
Risk calculators and risk factors for Lymphangioma

@@ Line 29: / Line 29: @@
 !
 [[Lymphangioma historical perspective|Historical Perspective]]
+|-
+!
+|- bgcolor="Pink"
+!
+[[Lymphangioma classification|Classification]]
 |-
 !
@@ Line 71: / Line 77: @@
 !
 Diagnosis
+|-
+!
+|- bgcolor="LightSkyBlue"
+!
+[[Lymphangioma diagnostic study of choice|Diagnostic Study of Choice]]
 |-
 !
@@ Line 94: / Line 106: @@
 |- bgcolor="LightSkyBlue"
 !
-[[Lymphangioma CT|CT]]
+[[Lymphangioma electrocardiogram|Electrocardiogram]]
 |-
 !
@@ Line 100: / Line 112: @@
 |- bgcolor="LightSkyBlue"
 !
-[[Lymphangioma MRI|MRI]]
+[[Lymphangioma x-ray|X-ray]]
 |-
 !
@@ Line 106: / Line 118: @@
 |- bgcolor="LightSkyBlue"
 !
-[[Lymphangioma echocardiography or ultrasound|Echocardiography or Ultrasound]]
+[[Lymphangioma CT|CT]]
+|-
+!
+|- bgcolor="LightSkyBlue"
+!
+[[Lymphangioma MRI|MRI]]
 |-
 !
@@ Line 144: / Line 162: @@
 [[Lymphangioma primary prevention|Primary Prevention]]
 |-
 !
 |- bgcolor="PaleTurquoise"
@@ Line 150: / Line 168: @@
 [[Lymphangioma secondary prevention|Secondary Prevention]]
 |-
 !
 |- bgcolor="PaleTurquoise"
@@ Line 162: / Line 180: @@
 [[Lymphangioma future or investigational therapies|Future or Investigational Therapies]]
 |-
 !
+|- bgcolor="CadetBlue"
+!
+Case Studies
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[Lymphangioma case study one|Case #1]]
+|-
+!
 |- bgcolor="PaleGoldenrod "

Latest revision as of 13:27, 6 August 2018